Yamo Pharmaceuticals
Biotechnology Research
750 Lexington Ave
8 employees
- Employees
- 8
- Contacts
- 3
- Emails
- 3
- Phones
- 3
Yamo Pharmaceuticals Overview
- Headquarters
- 750 Lexington Ave
- Website
- www.yamopharma.com
- Industry
- Biotechnology Research
- Employees
- 8
- Founded
- 2015
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Yamo Pharmaceuticals
Yamo Pharmaceuticals is developing L1-79, a novel therapy that targets the core symptoms of autism and has been well-tolerated by clinical trial patients to-date. The mechanism of action for L1-79 addresses both the central nervous system and metabolic symptoms of autism.
Yamo Pharmaceuticals Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 3
- 75.0% coverage
Yamo Pharmaceuticals Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Eugene Prahin | CFO and COO I Driving Corporate | New York, United States |
Email
Phone
|
| Larry G. |
View
|
||
| Tracy Fischer | Vice President Regulatory and Quality | Versailles, Kentucky, United States |
Email
Phone
|
| Chuck Bramlage | CEO at Yamo Pharmaceuticals | Columbus, Ohio Metropolitan Area, United States |
Email
Phone
|
Employees by Management Level
Executive
3 profiles
Compare Similar Companies to Yamo Pharmaceuticals
Vertex Pharmaceuticals
Biotechnology Research
Ingenus Pharmaceuticals
Pharmaceutical Manufacturing
ARS Pharmaceuticals, Inc.
Pharmaceutical Manufacturing
Mix Talent
Staffing And Recruiting
EarliTec Diagnostics, Inc.
Medical Equipment Manufacturing
Atossa Therapeutics, Inc.
Biotechnology
STALICLA
Biotechnology Research
Curemark, LLC
Biotechnology Research
Axial
Biotechnology Research
Scioto Biosciences, Inc
Biotechnology